PR
PALEKAR ROHAN Chairman & CEO
C-suite M
€328,471
▲ Purchases (6 ops.)
Insider track record CEO Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by PALEKAR ROHAN, Chairman & CEO. Director active across 1 company, notably 89bio, Inc.. Aggregated, 33 reports have been published. Split: 6 buys · 2 sells. Total volume traded: €594k. Activity tracked since 7 July 2021. The latest transaction was disclosed on 1 August 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations 33 total
● Chief Executive Officer · Executives · 1 Aug 2025 · 89bio, Inc. 55,836 shares @ US$9.16 20.2% of flow Common Stock SEC:0000950170-25-103374:0
● Chief Executive Officer · Executives · 17 Feb 2025 · 89bio, Inc. 3,249 shares @ US$10.57 1.5% of flow Common Stock SEC:0000950170-25-023119:0
● Chief Executive Officer · Executives · 9 Feb 2025 · 89bio, Inc. 8,946 shares @ US$11.41 4.4% of flow Common Stock SEC:0000950170-25-017866:0
◆ Chief Executive Officer · Executives · 1 Feb 2025 · 89bio, Inc. 212,000 shares 0Common Stock SEC:0000950170-25-014088:0
◆ Chief Executive Officer · Executives · 1 Feb 2025 · 89bio, Inc. 200,000 shares 0Common Stock SEC:0000950170-25-014088:1
● Chief Executive Officer · Executives · 1 Feb 2025 · 89bio, Inc. 9,598 shares @ US$9.60 4.0% of flow Common Stock SEC:0000950170-25-014088:2
▲ Chief Executive Officer · Executives · 6 Dec 2024 · 89bio, Inc. 5,000 shares @ US$7.89 1.7% of flow Common Stock SEC:0000950170-24-134750:0
Ideal exit: 2 Sept 2025 (T+270) ▲ Chief Executive Officer · Executives · 22 Nov 2024 · 89bio, Inc. 10,000 shares @ US$8.35 3.6% of flow Common Stock SEC:0000950170-24-130418:0
Ideal exit: 19 Aug 2025 (T+270) ● Chief Executive Officer · Executives · 17 Aug 2024 · 89bio, Inc. 4,601 shares @ US$8.04 1.5% of flow Common Stock SEC:0000950170-24-098698:0
◇ Chief Executive Officer · Executives · 1 Apr 2024 · 89bio, Inc. 25,000 shares @ US$1.93 2.0% of flow Common Stock SEC:0000950170-24-041024:0
▼ Chief Executive Officer · Executives · 26 Feb 2024 · 89bio, Inc. 4,477 shares @ US$10.76 2.0% of flow Common Stock SEC:0000950170-24-022433:0
● Chief Executive Officer · Executives · 17 Feb 2024 · 89bio, Inc. 4,602 shares @ US$9.74 1.9% of flow Common Stock SEC:0000950170-24-019662:0
● Chief Executive Officer · Executives · 9 Feb 2024 · 89bio, Inc. 12,670 shares @ US$8.45 4.5% of flow Common Stock SEC:0000950170-24-014886:0
◆ Chief Executive Officer · Executives · 1 Feb 2024 · 89bio, Inc. 150,000 shares 0Common Stock SEC:0000950170-24-011475:0
◆ Chief Executive Officer · Executives · 5 Jan 2024 · 89bio, Inc. 75,000 shares 0Common Stock SEC:0000950170-24-003105:0
◇ Chief Executive Officer · Executives · 29 Dec 2023 · 89bio, Inc. 50,000 shares @ US$1.93 3.9% of flow Common Stock SEC:0000950170-24-001035:0
● Chief Executive Officer · Executives · 17 Aug 2023 · 89bio, Inc. 4,501 shares @ US$15.46 2.9% of flow Common Stock SEC:0000899243-23-018332:0
◆ Chief Executive Officer · Executives · 30 Jun 2023 · 89bio, Inc. 33,334 shares 0Common Stock SEC:0000950170-23-031839:0
◇ Chief Executive Officer · Executives · 5 Jun 2023 · 89bio, Inc. 15,000 shares @ US$1.93 1.2% of flow Common Stock SEC:0000950170-23-026845:0
◆ Chief Executive Officer · Executives · 31 Mar 2023 · 89bio, Inc. 33,333 shares 0Common Stock SEC:0000899243-23-010403:0
● Chief Executive Officer · Executives · 31 Mar 2023 · 89bio, Inc. 15,443 shares @ US$15.23 9.7% of flow Common Stock SEC:0000899243-23-010403:1
▼ Chief Executive Officer · Executives · 23 Mar 2023 · 89bio, Inc. 15,000 shares @ US$16.00 10.0% of flow Common Stock SEC:0000950170-23-010075:0
● Chief Executive Officer · Executives · 17 Feb 2023 · 89bio, Inc. 6,279 shares @ US$13.97 3.7% of flow Common Stock SEC:0000899243-23-005875:0
◆ Chief Executive Officer · Executives · 9 Feb 2023 · 89bio, Inc. 75,000 shares 0Common Stock SEC:0000899243-23-004813:0
● Chief Executive Officer · Executives · 5 Feb 2023 · 89bio, Inc. 4,078 shares @ US$13.24 2.2% of flow Common Stock SEC:0000899243-23-004245:0
25 of 33 declarations
Load more (8 remaining) About PALEKAR ROHAN Rohan Palekar is the Chief Executive Officer of 89bio, Inc. In this role, he is responsible for the strategic direction of the company and innovation in the biotechnology field. Under his leadership, 89bio strives to develop innovative solutions to meet market needs. Rohan Palekar works closely with his team to achieve the company's growth objectives.